Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
The vatican meeting on neuroprotection for Parkinson's diseaseC Warren Olanow, Jose A Obeso, Fabrizio Stocchi
Nature Clinical Practice. Neurology|August 26, 2006
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's diseaseC Warren Olanow, José A Obeso, Fabrizio Stocchi
Neurology|May 24, 2006
Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's diseaseBiplob Dass, C Warren Olanow, Jeffrey H Kordower
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Milestones in movement disorders clinical trials: advances and landmark studiesC Warren Olanow, Kathryn B Wunderle, Karl Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin YahrAndrew J Lees, Eduardo Tolosa, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|August 21, 2020
Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future OpportunitiesC Warren Olanow, Paolo Calabresi, Jose A Obeso
Annals of Neurology|July 26, 2011
Open-label surgical trials for Parkinson disease: time for reconsiderationRon L Alterman, Michele Tagliati, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2013
Levodopa-induced dyskinesias in the absence of nigrostriatal degenerationErwan Bézard, C Warren Olanow, José A Obeso
Brain : a Journal of Neurology|August 17, 2002
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's diseaseFabrizio Stocchi, Stefano Ruggieri, Laura Vacca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 12, 2014
Scientific perspectivesDavid G Standaert, C Warren Olanow, José A Obeso
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
The vatican meeting on neuroprotection for Parkinson's diseaseC Warren Olanow, Jose A Obeso, Fabrizio Stocchi
Nature Clinical Practice. Neurology|August 26, 2006
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's diseaseC Warren Olanow, José A Obeso, Fabrizio Stocchi
Neurology|May 24, 2006
Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's diseaseBiplob Dass, C Warren Olanow, Jeffrey H Kordower
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Milestones in movement disorders clinical trials: advances and landmark studiesC Warren Olanow, Kathryn B Wunderle, Karl Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin YahrAndrew J Lees, Eduardo Tolosa, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|August 21, 2020
Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future OpportunitiesC Warren Olanow, Paolo Calabresi, Jose A Obeso
Annals of Neurology|July 26, 2011
Open-label surgical trials for Parkinson disease: time for reconsiderationRon L Alterman, Michele Tagliati, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2013
Levodopa-induced dyskinesias in the absence of nigrostriatal degenerationErwan Bézard, C Warren Olanow, José A Obeso
Brain : a Journal of Neurology|August 17, 2002
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's diseaseFabrizio Stocchi, Stefano Ruggieri, Laura Vacca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 12, 2014
Scientific perspectivesDavid G Standaert, C Warren Olanow, José A Obeso
Pageof 19